AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Gclazid M 60mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Xenon Pharmaceuticals

Salt Composition

Gliclazide (60mg) + Metformin (500mg)

Overview Gclazid M 60mg/500mg Tablet SR

Diabexe Duo 60mg/500mg Extended-Release Tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by managing blood glucose levels. Diabexe Duo should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial; discontinuation without medical supervision risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication complements a comprehensive diabetes management plan incorporating diet, exercise, and weight management as recommended by your doctor. Lifestyle choices significantly influence diabetes control. Common side effects of Diabexe Duo include hypoglycemia (low blood sugar), characterized by sweating, dizziness, headache, and tremors; constipation; and vomiting. Always carry a readily available fast-acting glucose source, like sugary snacks or juice, to counteract hypoglycemia. Alcohol consumption should be limited due to its potential to exacerbate low blood sugar. Less frequent side effects encompass altered taste, nausea, diarrhea, abdominal discomfort, cephalalgia, and upper respiratory infections. Weight gain is also a possibility. This medication is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Individuals with a history of cardiovascular disease should inform their physician before commencing treatment. Pregnant or lactating women should seek medical counsel prior to use. Regular blood glucose monitoring is essential, and your doctor may order blood tests to track blood cell counts and liver function.

Primary Ingredients of Gclazid M 60mg/500mg Tablet SR

No text provided. Please provide the text you wish me to rewrite.

Uses of Gclazid M 60mg/500mg Tablet SR

Adult-onset diabetes

Major Benefits of Gclazid M 60mg/500mg Tablet SR:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Gclazid M 60mg/500mg Tablet SR with a meal.

Common Side effects of Gclazid M 60mg/500mg Tablet SR:

  • Hypoglycemia (low blood glucose level)
  • Headache
  • Dizziness
  • Diarrhea
  • Upper respiratory tract infection
  • Nausea
  • Flatulence
  • Constipation

How to use Gclazid M 60mg/500mg Tablet SR:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. It's recommended to take Gclazid M 60mg/500mg Tablet SR with a meal.

How Gclazid M 60mg/500mg Tablet SR works:

Gliclazide and metformin, at doses of 60mg and 500mg respectively, are combined in the extended-release tablet, Gclazid M.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Gclazid M 60mg/500mg SR tablets with alcohol is not advisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The extended-release Gclazid M 60mg/500mg tablet poses a confirmed risk to fetal development and should not be taken during pregnancy. In exceptional circumstances involving immediate danger to the mother's life, a physician might consider its use only if the potential advantages outweigh the known hazards. Physician consultation is essential.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release Gclazid M 60mg/500mg tablets are likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Individuals with kidney impairment should exercise caution when using Gclazid M 60mg/500mg SR tablets, as dosage modification may be necessary. Consult your physician for guidance. For patients experiencing severe kidney disease, Gclazid M 60mg/500mg SR tablets are not recommended. Routine monitoring of kidney function is advised during treatment with this medication.

LiverLiverCAUTION

Individuals with liver impairment should exercise caution when using Gclazid M 60mg/500mg SR tablets. Dosage modification of Gclazid M 60mg/500mg SR tablets may be necessary. Physician consultation is advised. For patients experiencing mild to moderate liver disease, Gclazid M 60mg/500mg SR tablets are typically initiated at a reduced dosage; however, their use is contraindicated in cases of severe hepatic dysfunction.

What if you forget to take Gclazid M 60mg/500mg Tablet SR :

Should you forget to take a Gclazid M 60mg/500mg Tablet SR, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication regimen. Avoid taking a double dose.

Facts to Know About Gclazid M 60mg/500mg Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Gclazid M 60mg/500mg Tablet SR

Gclazid M 60mg/500mg SR tablets combine gliclazide and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's unsuitable for type 1 diabetes.
Gclazid M 60mg/500mg Tablet SR commonly causes side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects, including lactic acidosis, may occur. Prolonged use may also result in vitamin B12 deficiency.
Gclazid M 60mg/500mg Tablet SR can cause low blood sugar (hypoglycemia), characterized by nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and anxiety or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Therefore, regular blood sugar monitoring is crucial. Always carry glucose tablets, honey, or fruit juice.
Gclazid M 60mg/500mg Tablet SR can cause lactic acidosis, a serious medical emergency (also known as MALA, or Metformin-associated lactic acidosis) resulting from high blood lactic acid levels. This rare side effect is more likely in patients with kidney disease, older adults, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Gclazid M 60mg/500mg Tablet SR and seek immediate medical attention.
Prolonged use of Gclazid M 60mg/500mg Tablet SR can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, supplemental vitamin B12 is recommended at least annually.
Gclazid M 60mg/500mg Tablet SR is contraindicated in patients with allergies to its components or excipients, and in those with moderate to severe kidney disease or metabolic acidosis (including diabetic ketoacidosis).
Combining Gclazid M 60mg/500mg SR tablets with alcohol is unsafe. This combination can worsen low blood sugar and raise the risk of lactic acidosis.
Gclazid M 60mg/500mg SR tablets combine gliclazide and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood sugar control when used with diet and exercise. Gliclazide boosts insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. This medication is not suitable for type 1 diabetes.
Gclazid M 60mg/500mg SR Tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Gclazid M 60mg/500mg SR Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Gclazid M 60mg/500mg Tablet SR can cause lactic acidosis (MALA, or Metformin-associated lactic acidosis), a serious medical emergency resulting from excess blood lactic acid. This rare side effect is preventable by avoiding use in patients with kidney disease, the elderly, or those consuming excessive alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Gclazid M 60mg/500mg Tablet SR and seek immediate medical attention.
Prolonged use of Gclazid M 60mg/500mg Tablet SR can lead to vitamin B12 deficiency by interfering with its stomach absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and urinary issues), and cognitive changes (including balance problems). To mitigate these risks, supplemental vitamin B12 is recommended at least annually.
Gclazid M 60mg/500mg Tablet SR is contraindicated in patients with allergies to its components or excipients, and in those with moderate to severe kidney disease or metabolic acidosis (including diabetic ketoacidosis).
Combining Gclazid M 60mg/500mg SR tablets with alcohol is unsafe. This combination may worsen low blood sugar and raise the risk of lactic acidosis.
Gclazid M 60mg/500mg Tabl...
94
MRP 109
13% off